EGF induces microRNAs that target suppressors of cell migration: MiR-15b targets MTSS1 in breast cancer

Science Signaling

Volumn 8, Issue 368, 2015, Pages ra29-

  Kedmi, Merav ^a,g   Ben Chetrit, Nir ^a   Körner, Cindy ^b   Mancini, Maicol ^a   Ben Moshe, Noa Bossel ^a   Lauriola, Mattia ^a,h   Lavi, Sara ^a   Biagioni, Francesca ^c,i   Carvalho, Silvia ^a   Cohen Dvashi, Hadas ^a   Schmitt, Fernando ^d,e,f   Wiemann, Stefan ^b   Blandino, Giovanni ^c   Yarden, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF PORTO   (Portugal)

^g TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GUANINE NUCLEOTIDE BINDING PROTEIN; KALININ; LATROPHILIN 2; MESSENGER RNA; METASTASIS SUPPRESSOR PROTEIN 1; MICRORNA; MICRORNA 15B; MICRORNA 20A; SHORT HAIRPIN RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; MIRN15 MICRORNA, HUMAN; MTSS1 PROTEIN, HUMAN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STRESS FIBER; TUMOR INVASION; TUMOR XENOGRAFT; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL MOTION; FEMALE; GENETICS; METABOLISM; SCID MOUSE; TUMOR CELL LINE; XENOGRAFT;

MUS;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; FEMALE; HETEROGRAFTS; HUMANS; MICE; MICE, SCID; MICROFILAMENT PROTEINS; MICRORNAS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION;

EID: 84924961818     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005866     Document Type: Article

References (55)

1. N. E. Hynes, C. J. Watson, Mammary gland growth factors: Roles in normal development and in cancer. Cold Spring Harb. Perspect. Biol. 2, a003186 (2010).
2. E. Witsch, M. Sela, Y. Yarden, Roles for growth factors in cancer progression. Physiology 25, 85-101 (2010).
3. M. Katz, I.Amit, A. Citri, T. Shay, S. Carvalho, S. Lavi, F. Milanezi, L. Lyass, N. Amariglio, J. Jacob-Hirsch, N. Ben-Chetrit, G. Tarcic, M. Lindzen, R. Avraham, Y. C. Liao, P. Trusk, A. Lyass, G. Rechavi, N. L. Spector, S. H. Lo, F. Schmitt, S. S. Bacus, Y. Yarden, A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat. Cell Biol. 9, 961-969 (2007).
4. H. D. Kim, T. W. Guo, A. P. Wu, A. Wells, F. B. Gertler, D. A. Lauffenburger, Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix-and proteolysis-dependent increase in persistence. Mol. Biol. Cell 19, 4249-4259 (2008).
5. A. Albasri, M. Aleskandarany, A. Benhasouna, D. G. Powe, I. O. Ellis, M. Ilyas, A. R. Green, CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis. Breast Cancer Res. Treat. 126, 47-54 (2011).
6. I. Amit, A. Citri, T. Shay, Y. Lu, M. Katz, F. Zhang, G. Tarcic, D. Siwak, J. Lahad, J. Jacob-Hirsch, N. Amariglio, N. Vaisman, E. Segal, G. Rechavi, U. Alon, G. B. Mills, E. Domany, Y. Yarden, A module of negative feedback regulators defines growth factor signaling. Nat. Genet. 39, 503-512 (2007).
7. R. Avraham, A. Sas-Chen, O. Manor, I. Steinfeld, R. Shalgi, G. Tarcic, N. Bossel, A. Zeisel, I. Amit, Y. Zwang, E. Enerly, H. G. Russnes, F. Biagioni, M. Mottolese, S. Strano, G. Blandino, A. L. Borresen-Dale, Y. Pilpel, Z. Yakhini, E. Segal, Y. Yarden, EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors. Sci. Signal. 3, ra43 (2010).
8. R. Avraham, Y. Yarden, Feedback regulation of EGFR signalling: Decision making by early and delayed loops. Nat. Rev. Mol. Cell Biol. 12, 104-117 (2011).
9. L. Lin, Y. Lin, Y. Jin, C. Zheng, Microarray analysis of microRNA expression in liver cancer tissues and normal control. Gene 523, 158-160 (2013).
10. I. Satzger, A. Mattern, U. Kuettler, D. Weinspach, B. Voelker, A. Kapp, R. Gutzmer, MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int. J. Cancer 126, 2553-2562 (2010).
11. X. Wang, S. Tang, S. Y. Le, R. Lu, J. S. Rader, C. Meyers, Z. M. Zheng, Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLOS One 3, e2557 (2008).
12. Y. Xi, A. Formentini, M. Chien, D. B. Weir, J. J. Russo, J. Ju, M. Kornmann, J. Ju, Prognostic values of microRNAs in colorectal cancer. Biomark. Insights 2, 113-121 (2006).
13. H. Xia, Y. Qi, S. S. Ng, X. Chen, S. Chen, M. Fang, D. Li, Y. Zhao, R. Ge, G. Li, Y. Chen, M. L. He, H. F. Kung, L. Lai, M. C. Lin, MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem. Biophys. Res. Commun. 380, 205-210 (2009).
14. Y. G. Lee, J. A. Macoska, S. Korenchuk, K. J. Pienta, MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4, 291-294 (2002).
15. K. Liu, G. Wang, H. Ding, Y. Chen, G. Yu, J. Wang, Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer 10, 428 (2010).
16. C. Parr, W. G. Jiang, Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur. J. Cancer 45, 1673-1683 (2009).
17. H. Hirata, K. Ueno, V. Shahryari, G. Deng, Y. Tanaka, Z. L. Tabatabai, Y. Hinoda, R. Dahiya, MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLOS One 8, e55502 (2013).
18. Z. Liu, J. Liu, M. F. Segura, C. Shao, P. Lee, Y. Gong, E. Hernando, J. J. Wei, MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J. Pathol. 228, 204-215 (2012).
19. J. Wang, J. Li, J. Shen, C. Wang, L. Yang, X. Zhang, MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12, 227 (2012).
20. S. Jahid, J. Sun, R. A. Edwards, D. Dizon, N. C. Panarelli, J. W. Milsom, S. S. Sikandar, Z. H. Gümüs, S. M. Lipkin, miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov. 2, 540-553 (2012).
21. S. Liu, W. Guo, J. Shi, N. Li, X. Yu, J. Xue, X. Fu, K. Chu, C. Lu, J. Zhao, D. Xie, M. Wu, S. Cheng, S. Liu, MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J. Hepatol. 56, 389-396 (2012).
22. W. Zhou, X. Li, F. Liu, Z. Xiao, M. He, S. Shen, S. Liu, MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. Acta Biochim. Biophys. Sin. 44, 838-846 (2012).
23. 2-rich membranes by an inverse BAR domain-like mechanism. J. Cell Biol. 176, 953-964 (2007).
24. J. C. Dawson, S. Bruche, H. J. Spence, V. M. Braga, L. M. Machesky, Mtss1 promotes cell-cell junction assembly and stability through the small GTPase Rac1. PLOS One 7, e31141 (2012).
25. J. Saarikangas, P. K. Mattila, M. Varjosalo, M. Bovellan, J. Hakanen, J. Calzada-Wack, M. Tost, L. Jennen, B. Rathkolb, W. Hans, M. Horsch, M. E. Hyvönen, N. Perälä, H. Fuchs, V. Gailus-Durner, I. Esposito, E. Wolf, M. H. de Angelis, M. J. Frilander, H. Savilahti, H. Sariola, K. Sainio, S. Lehtonen, J. Taipale, M. Salminen, P. Lappalainen, Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithel ia. J. Cell Sci. 124, 1245-1255 (2011).
26. S. E. Seton-Rogers, Y. Lu, L M. Hines, M. Koundinya, J. LaBaer, S. K. Muthuswamy, J. S. Brugge, Cooperation of the ErbB2 receptor and transforming growth factor b in induction of migration and invasion in mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 101, 1257-1262 (2004).
27. G. Tarcic, R. Avraham, G. Pines, I. Amit, T. Shay, Y. Lu, Y. Zwang, M. Katz, N. Ben-Chetrit, J. Jacob-Hirsch, L. Virgilio, G. Rechavi, G. Mavrothalassitis, G. B. Mills, E. Domany, Y. Yarden, EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. FASEB J. 26, 1582-1592 (2012).
28. F. Biagioni, N. Bossel Ben-Moshe, G. Fontemaggi, V. Canu, F. Mori, B. Antoniani, A. Di Benedetto, R. Santoro, S. Germoni, F. De Angelis, A. Cambria, R. Avraham, G. Grasso, S. Strano, P. Muti, M. Mottolese, Y. Yarden, E. Domany, G. Blandino, miR-10b∗, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO Mol. Med. 4, 1214-1229 (2012).
29. E. Enerly, I. Steinfeld, K. Kleivi, S. K. Leivonen, M. R. Aure, H. G. Russnes, J. A. Rønneberg, H. Johnsen, R. Navon, E. Rødland, R. Mäkelä, B. Naume, M. Perälä, O. Kallioniemi, V. N. Kristensen, Z. Yakhini, A. L. Børresen-Dale, miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLOS One 6, e16915 (2011).
30. C. Blenkiron, L. D. Goldstein, N. P. Thorne, I. Spiteri, S. F. Chin, M. J. Dunning, N. L. Barbosa-Morais, A. E. Teschendorff, A. R. Green, I. O. Ellis, S. Tavaré, C. Caldas, E. A. Miska, MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8, R214 (2007).
31. H. Dvinge, A. Git, S. Gräf, M. Salmon-Divon, C. Curtis, A. Sottoriva, Y. Zhao, M. Hirst, J. Armisen, E. A. Miska, S. F. Chin, E. Provenzano, G. Turashvili, A. Green, I. Ellis, S. Aparicio, C. Caldas, The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497, 378-382 (2013).
32. N. Bossel Ben-Moshe, R. Avraham, M. Kedmi, A. Zeisel, A. Yitzhaky, Y. Yarden, E. Domany, Context-specific microRNA analysis: Identification of functional microRNAs and their mRNA targets. Nucleic Acids Res. 40, 10614-10627 (2012).
33. F. Xiao, Z. Zuo, G. Cai, S. Kang, X. Gao, T. Li, miRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Res. 37, D105-D110 (2009).
34. G. R. White, J. M. Varley, J. Heighway, Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancer. Oncogene 17, 3513-3519 (1998).
35. L. M. Machesky, S. A. Johnston, MIM: A multifunctional scaffold protein. J. Mol. Med. 85, 569-576 (2007).
36. R. D. Loberg, C. K. Neeley, L. L. Adam-Day, Y. Fridman, L. N. St. John, S. Nixdorf, P. Jackson, L. M. Kalikin, K. J. Pienta, Differential expression analysis of MIM (MTSS1) splice variants and afunctional role of MIM in prostate cancer cell biology. Int. J. Oncol. 26, 1699-1705 (2005).
37. J. Lin, J. Liu, Y. Wang, J. Zhu, K. Zhou, N. Smith, X. Zhan, Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene 24, 2059-2066 (2005).
38. D. A. Murphy, S. A. Courtneidge, The 'ins' and 'outs' of podosomes and invadopodia: Characteristics, formation and function. Nat. Rev. Mol. Cell Biol. 12, 413-426 (2011).
39. K. L. Burger, B. S. Learman, A. K. Boucherle, S. J. Sirintrapun, S. Isom, B. Diaz, S. A. Courtneidge, D. F. Seals, Src-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cells. Prostate 74, 134-148 (2014).
40. M. Bershteyn, S. X. Atwood, W. M. Woo, M. Li, A. E. Oro, MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling. Dev. Cell 19, 270-283 (2010).
41. P. K. Mattila, M. Salminen, T. Yamashiro, P. Lappalainen, Mouse MIM, a tissue-specific regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain. J. Biol. Chem. 278, 8452-8459 (2003).
42. R. Gonzalez-Quevedo, M. Shoffer, L. Horng, A. E. Oro, Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4. J. Cell Biol. 168, 453-463 (2005).
43. J. C. Dawson, P. Timpson, G. Kalna, L. M. Machesky, Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells. Oncogene 31, 1781-1793 (2012).
44. W. J. Köstler, A. Zeisel, C. Körner, J. M. Tsai, J. Jacob-Hirsch, N. Ben-Chetrit, K. Sharma, H. Cohen-Dvashi, A. Yitzhaky, E. Lader, U. Tschulena, G. Rechavi, E. Domany, S. Wiemann, Y. Yarden, Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration. PLOS One 8, e80566 (2013).
45. A. Zeisel, W. J. Köstler, N. Molotski, J. M. Tsai, R. Krauthgamer, J. Jacob-Hirsch, G. Rechavi, Y. Soen, S. Jung, Y. Yarden, E. Domany, Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli. Mol. Syst. Biol. 7, 529 (2011).
46. Y. Gómez-Gómez, J. Organista-Nava, P. Gariglio, Deregulation of the miRNAs expression in cervical cancer: Human papillomavirus implications. Biomed Res. Int. 2013, 407052 (2013).
47. L. Xia, D. Zhang, R. Du, Y. Pan, L. Zhao, S. Sun, L. Hong, J. Liu, D. Fan, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 123, 372-379 (2008).
48. M. P. Myklebust, O. Bruland, O. Fluge, A. Skarstein, L. Balteskard, O. Dahl, MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. Br. J. Cancer 105, 1719-1725 (2011).
49. M. Ofir, D. Hacohen, D. Ginsberg, MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol. Cancer Res. 9, 440-447 (2011).
50. L. Sun, Y. Yao, B. Liu, Z. Lin, L. Lin, M. Yang, W. Zhang, W. Chen, C. Pan, Q. Liu, E. Song, J. Li, MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 31, 432-445 (2012).
51. F. Xie, L. Ye, M. Ta, L. Zhang, W. G. Jiang, MTSS1: A multifunctional protein and its role in cancer invasion and metastasis. Front. Biosci. (Schol. Ed.) 3, 621-631 (2011).
52. R. Lei, J. Tang, X. Zhuang, R. Deng, G. Li, J. Yu, Y. Liang, J. Xiao, H. Y. Wang, Q. Yang, G. Hu, Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene 33, 1287-1296 (2014).
53. b-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration. Oncotarget 4, 2339-2353 (2013).
54. C. R. Pradeep, W. J. Köstler, M. Lauriola, R. Z. Granit, F. Zhang, J. Jacob-Hirsch, G. Rechavi, H. B. Nair, B. T. Hennessy, A. M. Gonzalez-Angulo, R. R. Tekmal, I. Ben-Porath, G. B. Mills, E. Domany, Y. Yarden, Modeling ductal carcinoma in situ: A HER2-Notch3 collaboration enables luminal filling. Oncogene 31, 907-917 (2012).
55. D. Tsafrir, I. Tsafrir, L. Ein-Dor, O. Zuk, D. A. Notterman, E. Domany, Sorting points into neighborhoods (SPIN): Data analysis and visualization by ordering distance matrices. Bioinformatics 21, 2301-2308 (2005).